Article in Journal of natural products, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Cody F DickinsonDepartment of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 70 President St, Charleston, South Carolina 29425, United States.ORCID 0000-0003-1318-4438
Samuel M FlipseDepartment of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii 96822, United States.
Jared S WoodDepartment of Chemistry & Biochemistry, University of North Carolina Wilmington, Wilmington, North Carolina 28403, United States.ORCID 0000-0002-3940-0461
Erika BistranDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425, United States.
Alison M BlandDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425, United States.
Daniel J SpragueDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425, United States.ORCID 0000-0002-0709-3284
Angelina M DeJohnDepartment of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 70 President St, Charleston, South Carolina 29425, United States.
Yeun-Mun ChooChemistry Department, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.ORCID 0000-0001-9891-5898
George S HannaDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, United States.ORCID 0000-0001-7616-064X
Wesley Y YoshidaDepartment of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii 96822, United States.
R Thomas WilliamsonDepartment of Chemistry & Biochemistry, University of North Carolina Wilmington, Wilmington, North Carolina 28403, United States.ORCID 0000-0001-7450-3135
Marcus A TiusDepartment of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii 96822, United States.ORCID 0000-0002-7092-8993
Mark T HamannDepartment of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 70 President St, Charleston, South Carolina 29425, United States.ORCID 0000-0002-3798-4002
Funding
Synthesis and Optimization of the Aleutianamine Class of AlkaloidsR01GM145845 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HAMANN, MARK T, TIUS, MARCUS ANTONIUS · 2022 to 2025
$2.4M
NIGMS NIH HHS R01 GM145845
6 · The paper itself
Abstract
We report a new optically active sulfoxide containing natural product isolated from an Alaskan
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Aleutianamine B, A Novel Chiral Sulfoxide Isolated from · full record | OpenQuestion